References
- Panny A H, Martin K C, Timothy C, Peter M, Stephen T H. Early and late-phase bronchoconstriction after allergen challenge of nonanesthetized guinea pigs. Am Rev Respir Dis 1988; 137: 548–557
- Holgate S T, Benyon R C, Howarth P H, Agius R, Hardy C, Robinson C, Durham S R, Kay A B, Church M K. Relationship between mediator release from human lung mast cells in vitro and in vivo. Int Arch Allergy Appl Immunol 1985; 77: 47–56
- Hargreave F E, Dolovich J, Robertson D G, Kerigan A T. The late asthmatic responses. Can Med Assoc J 1974; 110: 415–421
- Hanahan D J. Platelet activating factor: A biologically active phosphoglyceride. Anna Rev Biochem 1986; 55: 483–509
- Synker F. Platelet activating factor and related acetylated lipids as potent biologically active cellular mediators. Am J Physiol 1990; 259: C697–C708
- Prescott S M, Zimmerman G A, McIntyre T M. Platelet activating factor. J Biol Chem 1990; 265: 17381–17384
- Camussi G, Pawlowski I, Terta C, Roffinello C, Alberton M, Brentjens J, Andres G. Acute lung inflammation induced in the rabbit by local instillation of 1-O-octadecyl-2-acetyl-m-glyceryl-3-phosphorylcho- line or of native platelet-activating factor. Am J Pathol 1983; 112: 78–88
- Arnoux B, Denjean A, Page C P, Nolibe D, Morley J, Benveniste J. Accumulation of platelets and eosinophils in baboon lung after PAF-acether challenge. Am Rev Respir Dis 1988; 137: 855–860
- Wardlaw A J, Chung K F, Moqbel R, MacDonald A J, Hartnell A, McCusker M, Collins J V, Barnes P J, Kay A B. Effects of inhaled PAF in humans on circulating and bronchoalveolar lavage fluid neutrophils. Am Rev. Respir Dis 1990; 141: 386–392
- Wardlaw A J, Moqbel R, Cromwell O, Kay A B. Platelet-activating factor: A potent chemotactic and chemokinetic factor for human eosinophils. J Clin Invest 1986; 78: 1701–1706
- Evans T W, Chung K, Rogers D F, Barmes P J. Effect of platelet-activating factor on airway vascular permeability: Possible mechanisms. J Appl Physiol 1987; 63: 479–484
- Wirtz H, Lang M, Sannwald U, Hahn H. Mechanism of platelet activating factor (PAF)-induced secretion of mucus from tracheal submucosal glands in ferrets. Fed Proc 1986; 45: 418
- Aursudkij B, Rogers D F, Evans T F. Reduced tracheal mucus velocity in guinea pigs in vivo by platelet activating factor. Am Rev Respir Dis 1987; 135: A160
- Lai Y L. Maximal expiratory flow in the guinea-pig. Lung 1988; 166: 303–313
- Lai Y L, Zhang H Q. Axon reflex in reiniferatoxin-induced bronchoconstriction of guinea pigs. Respir Physiol 1993; 92: 13–25
- Nieri P, Daffonchio L, Ominit C, Martinotti E, Breschi M C. Changes in airway reactivity to exogenous and endogenous acetylcholine and substance P after anaphylactic bronchoconstriction in anaesthetized guinea-pigs. J Anton Pharmacol 1992; 12: 403–409
- Vargaftig B B, Lefort J, Chingard N, Benveniste J. Platelet-activating factor induces a platelet-dependent bronchoconstriction unrelated to the formation of prostaglandin derivatives. Eur J Pharmacol 1980; 65: 185–192
- Anderson G P, White H L, Fennesy M R. Increased airway responsiveness to histamine in the guinea-pig: Possible role of lipoxygenase metabolites. Agents Actions 1988; 24: 1–7
- Bentley A M, Menz G, Store C, Robinson D S, Bradley B, Jeffery P K, Durham S R, Kay A B. Identification of T lymphocytes, macrophages, and activated eosinophils in the bronchial mucosa in intrinsic asthma. Relationship to symptoms and bronchal responsiveness. Am Rev Respir Dis 1992; 146: 500–506
- Bousquet J, Chanez P, Lacoste J Y, Bameon G, Ghavanian N, Enander I, Venge P, Ahstedt S, Simony-Lafontaine J, Godard P. Eosinophilic inflammation in asthma. N Engl J Med 1990; 323: 1033–1039
- Djukanovic R, Roche W R, Wilson J W, Beasley C R, Twentyman O P, Howarth R H, Holgate S T. Mucosal inflammation in atshma. Am Rev Respir Dis 1990; 142: 434–457
- Djukanovic R, Wilson J W, Britten K M, Wilson S J, Walls A F, Roche W R, Howarth P H, Holgate S T. Quantitation of mast cells and eosinophils in the bronchial mucosa of symptomatic atopic asthmatics and healthy control subjects using immunohistochemistry. Am Rev Respir Dis 1990; 142: 863–871
- Lellouch-Tubiana A, Lefort J, Simon M T, Pfister A, Vargaftig B B. Eosinophil recruitment into guinea pig lungs after PAF-acether and allergen administration. Am Rev Respir Dis 1988; 137: 948–954
- Robinson C, Holgate S T. The role of leukotrienes and prostaglandins in asthma: Evidence from clinical investigation. Adv Prostaglandin Thromboxane Leukotriene Res 1990; 20: 209–216
- Kuitert L M, Angus R M, Barnes N C, Barnes P J, Bone M F, Chung K F, Fairfax A J, Higenbotham T W, O'Connor B J, Piotrowska B, Rozniecki J, Uden S, Walters E H, Willard C J. Effect of a novel potent platelet-activating factor antagonist modipafant in clinical asthma. Am J Respir Crit Care Med 1995; 151: 1331–1335
- Tsukagoshi H, Aoki S, Kurosawa M. Bronchial hyper-responsiveness to histamine in guinea pig induced by intravenous administration of platelet activating factor. Jpn J Thorac Dis 1990; 28: 1450–1455
- Uchida M, Sugasawa T, Imanishi N, Komuro Morooka Y. S. Effect of a selective PAF-antagonist, SM-10661 on asthmatic responses. Third International Conference on Platelet-Activating Factor and Structurally Related Alkyl Ether Lipids. 1989, 210, Abstracts